A shadow market for unapproved weight-loss medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Vendors market the substance there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Worries
However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of unknown origin.
Some experts said the demand for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has taken down violative content and banned related hashtags and query recommendations. The company said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, positive testimonials and detailed guides for preparing or administering at home.
Within minutes of entering one group, a vendor posted contact information, where most transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.
Item Information and Pricing
Inside these groups, messages show dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they cannot confirm. Even if the research behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to potentially significant health risks”.
